Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Dow
McKesson
Johnson and Johnson
Moodys

Last Updated: May 17, 2022

ABILIFY MYCITE KIT Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Abilify Mycite Kit, and when can generic versions of Abilify Mycite Kit launch?

Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. There are thirty-two patents protecting this drug.

This drug has six hundred and seventy-one patent family members in forty-one countries.

The generic ingredient in ABILIFY MYCITE KIT is aripiprazole. There are forty-nine drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the aripiprazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Abilify Mycite Kit

A generic version of ABILIFY MYCITE KIT was approved as aripiprazole by ALEMBIC PHARMS LTD on April 28th, 2015.

  Try it Free

Drug patent expirations by year for ABILIFY MYCITE KIT
Recent Clinical Trials for ABILIFY MYCITE KIT

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 4

See all ABILIFY MYCITE KIT clinical trials

Pharmacology for ABILIFY MYCITE KIT
Anatomical Therapeutic Chemical (ATC) Classes for ABILIFY MYCITE KIT

US Patents and Regulatory Information for ABILIFY MYCITE KIT

ABILIFY MYCITE KIT is protected by thirty-four US patents.

Patents protecting ABILIFY MYCITE KIT

Ingestible event marker systems
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Communication system with enhanced partial power source and method of manufacturing same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Communication system with enhanced partial power source and method of manufacturing same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

5-HT1a receptor subtype agonist
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Communication system with partial power source
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Body-associated receiver and method
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Multi-mode communication ingestible event markers and systems, and methods of using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Highly reliable ingestible event markers and methods for using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Implantable zero-wire communications system
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Pharma-informatics system
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A RECEIVER TO RECEIVE A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT

Active signal processing personal health signal receivers
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Pharma-informatics system
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

Controlled activation ingestible identifier
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

In-body power source having high surface area electrode
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

In-body device with virtual dipole signal amplification
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Multi-mode communication ingestible event markers and systems, and methods of using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Method of treating cognitive impairments and schizophrenias
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF SCHIZOPHRENIA

Pharma-informatics system
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Carbostyril derivatives and mood stabilizers for treating mood disorders
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER

Body-associated receiver and method
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Multi-mode communication ingestible event markers and systems, and methods of using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER

Highly reliable ingestible event markers and methods for using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MANIC AND MIXED EPISODES ASSOCIATED WITH BIPOLAR I DISORDER

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF SCHIZOPHRENIA

Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

In-body device with virtual dipole signal amplification
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Active signal processing personal health signal receivers
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF USING A RECEIVER TO IDENTIFY A SIGNAL FROM A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION THROUGH THE BODY OF A PATIENT

System for supply chain management
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-002 Nov 13, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-001 Nov 13, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-005 Nov 13, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-005 Nov 13, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ABILIFY MYCITE KIT

International Patents for ABILIFY MYCITE KIT

See the table below for patents covering ABILIFY MYCITE KIT around the world.

Country Patent Number Title Estimated Expiration
Russian Federation 2628404 СПОСОБЫ, УСТРОЙСТВА И СИСТЕМЫ ПРИЕМА И ДЕКОДИРОВАНИЯ СИГНАЛОВ В ПРИСУТСТВИИ ШУМА С ИСПОЛЬЗОВАНИЕМ СРЕЗОВ И ДЕФОРМИРОВАНИЯ (METHODS, DEVICES AND SYSTEMS OF SIGNALS RECEIVING AND DECODING IN THE PRESENCE OF NOISE USING THE SHEARS AND DEFORMATION) See Plans and Pricing
Australia 2008216170 In-body power source having high surface area electrode See Plans and Pricing
Israel 253008 התקן מוקטן הניתן לבליעה (Miniature ingestible device) See Plans and Pricing
Cyprus 1110212 See Plans and Pricing
Norway 336264 See Plans and Pricing
China 101636865 In-body power source having high surface area electrode See Plans and Pricing
China 103751118 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ABILIFY MYCITE KIT

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0367141 SPC/GB04/039 United Kingdom See Plans and Pricing PRODUCT NAME: ARIPIPRAZOLE OR A SALT THEREOF; REGISTERED: UK EU/1/04/276/001 20040604; UK EU/1/04/276/002 20040604; UK EU/1/04/276/003 20040604; UK EU/1/04/276/004 20040604; UK EU/1/04/276/005 20040604; UK EU/1/04/276/006 20040604; UK EU/1/04/276/007 20040604; UK EU/1/04/276/008 20040604; UK EU/1/04/276/009 20040604; UK EU/1/04/276/010 20040604; UK EU/1/04/276/011 20040604; UK EU/1/04/276/012 20040604; UK EU/1/04/276/013 20040604; UK EU/1/04/276/014 20040604; UK EU/1/04/276/015 20040604; UK EU/1/04/276/016 20040604; UK EU/1/04/276/017 20040604; UK EU/1/04/276/018 20040604; UK EU/1/04/276/019 20040604; UK EU/1/04/276/020 20040604
1675573 300669 Netherlands See Plans and Pricing PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115
1675573 C300669 Netherlands See Plans and Pricing PRODUCT NAME: ARIPIPRAZOLE; REGISTRATION NO/DATE: EU/1/13/882 20131115
1675573 2014C/029 Belgium See Plans and Pricing PRODUCT NAME: ARIPIPRAZOLE; AUTHORISATION NUMBER AND DATE: EU/1/13/882 20131119
1675573 92427 Luxembourg See Plans and Pricing PRODUCT NAME: ARIPIPRAZOLE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Merck
Medtronic
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.